Olympus (OTCMKTS:OCPNY) Stock Price Passes Below 200 Day Moving Average – Time to Sell?

Olympus Co. (OTCMKTS:OCPNY) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares traded.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised shares of Olympus to a “buy” rating in a research report on Monday, May 18th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy”.

Olympus Price Performance

The firm has a market cap of $23.15 billion, a P/E ratio of 21.95, a P/E/G ratio of 1.07 and a beta of 0.70. The company has a fifty day moving average of $18.00 and a 200-day moving average of $18.00. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.99 and a quick ratio of 1.48.

About Olympus

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.